447 related articles for article (PubMed ID: 2166057)
1. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
[TBL] [Abstract][Full Text] [Related]
2. Use of lanthanum to accurately quantify insulin-like growth factor binding to proteins on cell surfaces.
McCusker RH; Clemmons DR
J Cell Biochem; 1997 Aug; 66(2):256-67. PubMed ID: 9213226
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.
McCusker RH; Busby WH; Dehoff MH; Camacho-Hubner C; Clemmons DR
Endocrinology; 1991 Aug; 129(2):939-49. PubMed ID: 1713163
[TBL] [Abstract][Full Text] [Related]
4. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
5. A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.
Conover CA
J Clin Invest; 1991 Oct; 88(4):1354-61. PubMed ID: 1717510
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
7. Expression of two types of receptor for insulin-like growth factors in human malignant glioma.
Gammeltoft S; Ballotti R; Kowalski A; Westermark B; Van Obberghen E
Cancer Res; 1988 Mar; 48(5):1233-7. PubMed ID: 2963688
[TBL] [Abstract][Full Text] [Related]
8. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
[TBL] [Abstract][Full Text] [Related]
9. Binding of insulin-like growth factors to cultured rat calvarial cells with differing biologic responses.
Cantrell PR; Frolik CA; Ellis LF; Williams DC
J Bone Miner Res; 1991 Aug; 6(8):851-7. PubMed ID: 1664647
[TBL] [Abstract][Full Text] [Related]
10. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
Myal Y; Shiu RP; Bhaumick B; Bala M
Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
12. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Minniti CP; Maggi M; Helman LJ
Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I receptors in normal and neoplastic human endometrium.
Talavera F; Reynolds RK; Roberts JA; Menon KM
Cancer Res; 1990 May; 50(10):3019-24. PubMed ID: 2159368
[TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin-like growth factor binding protein synthesis and secretion in human retinal pigment epithelial cells.
Feldman EL; Randolph AE
J Cell Physiol; 1994 Jan; 158(1):198-204. PubMed ID: 7505278
[TBL] [Abstract][Full Text] [Related]
15. Zinc partitions insulin-like growth factors (IGFs) from soluble IGF binding protein (IGFBP)-5 to the cell surface receptors of BC3H-1 muscle cells.
McCusker RH; Novakofski J
J Cell Physiol; 2003 Dec; 197(3):388-99. PubMed ID: 14566968
[TBL] [Abstract][Full Text] [Related]
16. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.
Fleck JF; Sledge GW; Benenati SV; Frolik CA; Roth BJ; Hirsch KS
Cancer Res; 1991 Aug; 51(16):4395-401. PubMed ID: 1678315
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
[TBL] [Abstract][Full Text] [Related]
18. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
